Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Sexually Transmitted Diseases 1Lymphoma 1Hypergammaglobulinemia 1Exanthema 1Disease 1Dermatitis, Seborrheic 1Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma × HIV Testing × Clear all
NCT01196468 2012-04-12

HIV Indicator Diseases Survey Across Europe - UK Arm

Chelsea and Westminster NHS Foundation Trust

Unknown
2,000 enrolled
GynecologicLymphoid

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Disease, Exanthema, Hypergammaglobulinemia, Lymphoma, Dermatitis, Seborrheic, Sexually Transmitted Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡